FDA Clears Tevogen Bio’s Investigational CTL COVID-19 Treatment July 13, 2021 Auto Bot News 0 The IND for TVGN-489, Allogeneic COVID-19 Specific Cytotoxic T Lymphocytes, received rapid clearance from FDA.
